Bellevue Hosp / New York Univ Med Ctr
New York, New York, United States
Hospital in New York City, New York
462 1st Ave., New York, NY 10016
844 (2015) Beds
About Bellevue Hosp / New York Univ Med Ctr
Bellevue Hospital is a hospital in New York City and the oldest public hospital in the United States. One of the largest hospitals in the United States by number of beds, it is located at 462 First Avenue in the Kips Bay neighborhood of Manhattan, New York City.
There are 844 (2015) beds in Bellevue Hosp / New York Univ Med Ctr.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Institute of Allergy and Infectious Diseases (NIAID)
106
NYU Langone Health
53
Pfizer
4
AIDS Clinical Trials Group
2
Health Decisions
2
Hoffmann-La Roche
2
Memorial Sloan Kettering Cancer Center
2
National Cancer Institute (NCI)
2
New York University
2
University of California, Los Angeles
2
University of Washington
2
Clinical Trials at Bellevue Hosp / New York Univ Med Ctr
During the past decade, Bellevue Hosp / New York Univ Med Ctr conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 25 clinical trials were completed, i.e. on
average, 58.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 13 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children
1996-09-01
Completed
819
Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
1999-09-01
Completed
2,000
A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals
1996-02-01
Completed
100
A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC)
Terminated
80
Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma
1992-07-01
Completed
24
A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
Completed
750
An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex
Completed
660
A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection
1990-08-01
Completed
315
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Bellevue Hosp / New York Univ Med Ctr" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 106 trials, followed by "NYU Langone Health" with 53 trials
sponsored, "Pfizer" with 4 trials sponsored, "AIDS Clinical Trials Group" with 2 trials sponsored and "Health Decisions"
with 2 trials sponsored. Other sponsors include 36 different institutions and
companies that sponsored additional 40 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Bellevue Hosp / New York Univ Med Ctr"
#1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 14 trials as a collaborator, "Bristol-Myers Squibb" with 10 trials as a collaborator, "Glaxo Wellcome" with 9 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 8 trials as a collaborator and "NYU Langone Health" with 7 trials as a collaborator. Other collaborators include 112 different institutions and companies that were
collaborators in the rest 93 trials.
Clinical Trials Conditions at Bellevue Hosp / New York Univ Med Ctr
According to Clinical.Site data, the most researched conditions in "Bellevue Hosp / New York Univ Med Ctr" are
"HIV Infections" (119 trials), "Pregnancy" (9 trials), "Schizophrenia" (6 trials), "Breast Cancer" (5 trials) and "Pneumonia, Pneumocystis Carinii" (5 trials). Many other conditions were trialed in "Bellevue Hosp / New York Univ Med Ctr" in a lesser frequency.
Clinical Trials Intervention Types at Bellevue Hosp / New York Univ Med Ctr
Most popular intervention types in "Bellevue Hosp / New York Univ Med Ctr" are "Drug" (133 trials), "Behavioral" (19 trials), "Other" (18 trials), "Device" (9 trials) and "Procedure" (7 trials). Other intervention types were less common.
The name of intervention was led by "Zidovudine" (34 trials), "Didanosine" (16 trials), "Stavudine" (15 trials), "Nevirapine" (14 trials) and "Lamivudine" (13 trials). Other intervention names were less common.
Clinical Trials Genders at Bellevue Hosp / New York Univ Med Ctr
The vast majority of trials in "Bellevue Hosp / New York Univ Med Ctr" are
181 trials for "All" genders, 23 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Bellevue Hosp / New York Univ Med Ctr
Currently, there are NaN active trials in "Bellevue Hosp / New York Univ Med Ctr".
undefined are not yet recruiting,
17 are recruiting,
5 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 160 completed trials in Bellevue Hosp / New York Univ Med Ctr,
undefined suspended trials,
and 10 terminated clinical trials to date.
Out of the total trials that were conducted in Bellevue Hosp / New York Univ Med Ctr, 25 "Phase 1"
clinical trials were conducted, 58 "Phase 2" clinical
trials and 37 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 11 trials, and there were
also 41 trials that are defined as “Not Applicable".